Cinzia has headed NousCom’s Regulatory Affairs since its foundation. Previously she held the same role in Okairos and ReiThera. She coordinated several projects in the field of humoral immune response against hepatitis C virus (HCV), in vivo models of HCV replication and drug development against HCV targets.
Before moving to the private sector, Cinzia was Professor of Molecular Genetics at the Medical School of the University of Rome, La Sapienza. She received a degree in biology and a PhD in microbiology from the University of Naples, and was a postdoctoral fellow at EMBL.
She has been the author of articles in leading journals on a number of subjects and has strong expertise in clinical research organization and regulatory affairs.